Posted on 02/14/2012 9:31:31 AM PST by alancarp
Edited on 02/14/2012 10:36:22 AM PST by Admin Moderator. [history]
A national drug shortage is threatening to disrupt cancer therapy for 24-year-old Tammie Miura and at least 100 Hawaii patients who use the medicine as a main source of treatment.
Hospital officials nationwide are fearful that the drug, methotrexate a crucial medicine in the treatment of childhood cancers will be exhausted within the next two weeks after a major supplier stopped producing it in November. Hawaii has not yet seen a shortage because local hospitals typically stock up on the drug, though medical providers and patients are worried that could soon change. [snip]
As noted, this is not a problem limited to Hawaii - it is a nationwide shortage, and news reports are now hitting the air. As you can see from the article, though, it's a problem that's been coming over the past 4 months.
Interesting since the FDA determins quantity of meds made these days.
God bless your son. I pray this shortage consequence of Obamacare does not touch him as he heals from cancer.
Thank you - I am hopeful that we’ll have completed his treatments by the time that obamanation gets fully implemented... assuming all other avenues to stymie that agenda fail.
Besides making methotrexate, the factory was the sole source for Johnson & Johnson's Doxil, a drug widely used for breast and ovarian cancer that's not been available for new patients for months.
Another foreign-owned generic manufacturer struggling to understand how the FDA works. Boehringer Ingelheim owns them.
I would've guessed it was related to a lawsuit.
Just your government doing it's thing.
Their take on events is here.
Funny how that got approved even though they need major construction to get in compliance.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.